FDA Import Refusal 1FX-4385526-1/10002/1 — GLAXO SMITH KLINE
The FDA refused shipment 1FX-4385526-1/10002/1 from GLAXO SMITH KLINE (India) on Jul 24, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 24, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LCA01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 75